Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BUDDY: Atezolizumab and Blood TMB in 2nd Line NSCLC
NCT04059887Phase 4Completed
- Sponsor
- Chonnam National University Hospital
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of atezolizumab in non-small cell lung cancer (NSCLC), sponsored by Chonnam National University Hospital. Started Dec 2019; status: completed.
02
Drugs
atezolizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04059887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04059887.